BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3487881)

  • 1. Epidemiology of delta agent infection in Arabia: geographical distribution and prevalence of anti-delta.
    el-Hazmi MA; Ramia S
    Vox Sang; 1986; 50(4):216-9. PubMed ID: 3487881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.
    Rizzetto M; Purcell RH; Gerin JL
    Lancet; 1980 Jun; 1(8180):1215-8. PubMed ID: 6104036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis delta antibody among HBsAG carriers in Saudi Arabia.
    Al-Traif I; Ali A; Dafalla M; Al-Tamimi W; Qassem L
    Ann Saudi Med; 2004; 24(5):343-4. PubMed ID: 15573844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus in Saudi Arabia.
    el-Hazmi MA
    J Trop Med Hyg; 1989 Feb; 92(1):56-61. PubMed ID: 2918579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta agent infection in Riyadh, Saudi Arabia.
    Ramia S; el-Hazmi MA; Vivian PA; Waller DK; Mushahwar IK; Frösner GG
    Trans R Soc Trop Med Hyg; 1987; 81(2):317-8. PubMed ID: 3617196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta hepatitis in Malaysia.
    Sinniah M; Dimitrakakis M; Tan DS
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta hepatitis in Lebanon. Prevalence studies and a report on six siblings with chronic delta-positive active hepatitis.
    Farci P; Burroughs AK; Thomas HC; Shamma'a M
    J Hepatol; 1987 Apr; 4(2):224-8. PubMed ID: 3584931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and delta markers in primary hepatocellular carcinoma patients in the Gizan area of Saudi Arabia.
    Arya SC; Ashraf SJ; Parande CM; Tobeiqi MS; Ageel AR
    APMIS Suppl; 1988; 3():30-4. PubMed ID: 2846019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of delta antigen/antibody in various HBsAg positive patients in Saudi Arabia.
    Shobokshi OA; Serebour FE
    Prog Clin Biol Res; 1987; 234():471-5. PubMed ID: 2819896
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequencies of hepatitis B, delta and HTLV-III virus markers in Saudi Arabia.
    Ashraf SJ; Arya SC; Arendrup M; Krogsgaard K; Parande CM; Orskov B; Ageel AR
    Liver; 1986 Apr; 6(2):73-7. PubMed ID: 3461233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers.
    Alzahrani FM; Muzaheed ; Shaikh SS; Alomar AI; Acharya S; Elhadi N
    Ann Lab Med; 2019 Jan; 39(1):81-85. PubMed ID: 30215234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis delta virus infection in Kenya. Its geographic and tribal distribution.
    Greenfield C; Farci P; Osidiana V; Macpherson CN; Romig T; Zeyhle E; French M; Johnson B; Tukei P; Wankya BM
    Am J Epidemiol; 1986 Mar; 123(3):416-23. PubMed ID: 3946387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of blood-borne viral infections in Afghanistan.
    Husseini AA; Saeed KMI; Yurdcu E; Sertoz R; Bozdayi AM
    Arch Virol; 2019 Aug; 164(8):2083-2090. PubMed ID: 31134354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of hepatitis B, C and D prevalence among urban and Amerindian populations from the Eastern Brazilian Amazon: a cross sectional study.
    Villar LM; Milagres FAP; Lampe E; Cruz HM; Scalioni LP; Magalhães MAFM; Romão AR; Gracie R; de Paula VS
    BMC Infect Dis; 2018 Aug; 18(1):411. PubMed ID: 30126364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV, HBV, delta-agent and Treponema pallidum infections in two rural African areas.
    de Lalla F; Rizzardini G; Rinaldi E; Santoro D; Zeli PL; Verga G
    Trans R Soc Trop Med Hyg; 1990; 84(1):144-7. PubMed ID: 2189236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of serological markers of viral hepatitis A, B and delta in apparently healthy schoolchildren of Huanta, Peru].
    Cabezas C; Gotuzzo E; Escamilla J; Phillips I
    Rev Gastroenterol Peru; 1994; 14(2):123-34. PubMed ID: 7948940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequencies of hepatitis B, delta and human immune deficiency virus markers in multitransfused Saudi patients with thalassaemia and sickle-cell disease.
    el-Hazmi MA; Ramia S
    J Trop Med Hyg; 1989 Feb; 92(1):1-5. PubMed ID: 2918572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibody to hepatitis D virus among HBsAg-positive drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J; Zimmo S
    East Afr Med J; 1998 Jun; 75(6):327-8. PubMed ID: 9803612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.